Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.75 EUR | -0.09% |
|
-1.30% | -10.27% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,085B | A | |||||||
| 624B | BBB | |||||||
| 442B | AA | - | ||||||
| 332B | AA | |||||||
| 277B | A | |||||||
| 282B | AAA | |||||||
| 217B | A | |||||||
| 196B | A | |||||||
| 167B | AA | |||||||
| 138B | A | |||||||
| 126B | AA | |||||||
| 118B | A | |||||||
| 105B | AA | |||||||
| 105B | AA | |||||||
| 74.59B | AA | |||||||
| 56.94B | AA | |||||||
| 52.53B | AA | |||||||
| 54B | AA | |||||||
| 41.76B | AA | |||||||
| Average | 236.52B | AA | |||||||
| Weighted average by Cap. | AA |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
